Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SLGC - SomaLogic Inc - Class A


IEX Last Trade
2.13
-0.090   -4.225%

Share volume: 947,634
Last Updated: Tue 08 Aug 2023 09:59:58 PM CEST
Testing Laboratories: -4.68%

PREVIOUS CLOSE
CHG
CHG%

$2.22
-0.09
-4.05%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
10%
Profitability 0%
Dept financing 18%
Liquidity 75%
Performance 1%
Company vs Stock growth
vs
Performance
5 Days
-9.39%
1 Month
1.83%
3 Months
-23.71%
6 Months
-35.65%
1 Year
-56.39%
2 Year
-80.68%
Key data
Stock price
$2.13
P/E Ratio 
0.00
DAY RANGE
N/A - $2.22
EPS 
$0.00
52 WEEK RANGE
$1.98 - $4.73
52 WEEK CHANGE
-$0.52
MARKET CAP 
417.239 M
YIELD 
N/A
SHARES OUTSTANDING 
187.945 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.74
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$814,260
AVERAGE 30 VOLUME 
$829,768
Company detail
CEO: Adam Taich
Region: US
Website: somalogic.com
Employees: 517
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Testing Laboratories
Sector: Professional, Scientific, and Technical Services

revolutionizing proteomics to transform healthcare somalogic was founded in 2000 with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected and diagnosed. building on the previous decade of aptamer research, somalogic scientists have developed a new proteomics technology that overcomes the significant challenges of current technologies, and which has multiple applications across the biological and medical sciences. our mission is to leverage our proprietary technology to discover, develop and commercialize revolutionary new life science research tools and breakthrough clinical diagnostic products that will transform healthcare. if you would like to learn more about somalogic, contact us at information@somalogic.com or 303-625-9000

Recent news